Literature DB >> 17019373

Micronutrient levels and HIV disease status in HIV-infected patients on highly active antiretroviral therapy in the Nutrition for Healthy Living cohort.

Clara Y Jones1, Alice M Tang, Janet E Forrester, Jinyong Huang, Kristy M Hendricks, Tamsin A Knox, Donna Spiegelman, Richard D Semba, Margo N Woods.   

Abstract

BACKGROUND: Low serum micronutrient levels were common before widespread use of highly active antiretroviral therapy (HAART) and were associated with adverse outcomes. Few data are available on micronutrient levels in subjects taking HAART.
OBJECTIVE: To determine the prevalence of low serum retinol, alpha-tocopherol, zinc, and selenium in HIV-infected subjects taking HAART and to assess the association of micronutrient levels with HIV disease status.
DESIGN: Cross-sectional.
SETTING: Nutrition for Healthy Living (NFHL) study. PARTICIPANTS: HIV-infected subjects on HAART.
METHODS: Retinol, alpha-tocopherol, zinc, and selenium were determined in frozen serum samples from 171 men and 117 women. Low serum levels were defined as retinol <30 microg/dL, selenium <85 microg/L, alpha-tocopherol <500 microg/dL, and zinc <670 microg/L. Association of micronutrient quartiles with CD4 cell count, CD4 count <200 cells/mm, HIV viral load (VL), and undetectable VL was assessed using adjusted multivariate regression.
RESULTS: Five percent of men and 14% of women had low retinol, 8% of men and 3% of women had low selenium, and 7% of men and no women had low alpha-tocopherol. Forty percent of men and 36% of women had low zinc, however. Subjects in the upper quartiles of zinc had lower log VL levels than those in the lowest quartile (significant for women). Subjects in the upper quartiles of selenium also tended to have lower VL levels compared with those in the lowest quartile. Surprisingly, women in the upper quartiles of retinol had higher log VLs than those in the lowest quartile. There was no significant association of any micronutrient with CD4 cell count or likelihood of CD4 count <200 cells/mm. The level of CD4 cell count influenced the association of retinol with log VL in men, however. In men with CD4 counts >350 cells/mm, those with higher retinol had higher log VLs compared with the lowest quartile, whereas in men with CD4 counts <350, those with higher retinol levels had lower log VLs compared with the lowest quartile.
CONCLUSIONS: Low retinol, alpha-tocopherol, and selenium are uncommon in HIV-infected subjects on HAART. Zinc deficiency remains common, however. Decreased retinol levels in women and in men with CD4 counts >350 cells/mm and increased zinc and selenium levels in both genders may be associated with improved virologic control.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019373     DOI: 10.1097/01.qai.0000243096.27029.fe

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  38 in total

1.  Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults.

Authors:  Marianna K Baum; Shenghan Lai; Sabrina Sales; J Bryan Page; Adriana Campa
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

2.  Plasma Micronutrient Concentrations Are Altered by Antiretroviral Therapy and Lipid-Based Nutrient Supplements in Lactating HIV-Infected Malawian Women.

Authors:  Valerie L Flax; Linda S Adair; Lindsay H Allen; Setarah Shahab-Ferdows; Daniela Hampel; Charles S Chasela; Gerald Tegha; Eric J Daza; Amanda Corbett; Nicole L Davis; Deborah Kamwendo; Athena P Kourtis; Charles M van der Horst; Denise J Jamieson; Margaret E Bentley
Journal:  J Nutr       Date:  2015-07-08       Impact factor: 4.798

3.  Integration of nutrition in the antiretroviral therapy scale up plan for Malawi.

Authors:  Thomas Bisika; George Mandere
Journal:  Malawi Med J       Date:  2008-09       Impact factor: 0.875

4.  Dietary Intake and Serum Selenium Levels Influence the Outcome of HTLV-1 Infection.

Authors:  Effat Saghi; Abdolreza Norouzy; Mohsen Nematy; Lida Jarahi; Reza Boostani; Fariba Zemorshidi; Zohreh Vahidi; Houshang Rafatpanah
Journal:  Biol Trace Elem Res       Date:  2020-11-09       Impact factor: 3.738

5.  Plasma and breast-milk selenium in HIV-infected Malawian mothers are positively associated with infant selenium status but are not associated with maternal supplementation: results of the Breastfeeding, Antiretrovirals, and Nutrition study.

Authors:  Valerie L Flax; Margaret E Bentley; Gerald F Combs; Charles S Chasela; Dumbani Kayira; Gerald Tegha; Debbie Kamwendo; Eric J Daza; Ali Fokar; Athena P Kourtis; Denise J Jamieson; Charles M van der Horst; Linda S Adair
Journal:  Am J Clin Nutr       Date:  2014-02-05       Impact factor: 7.045

6.  Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.

Authors:  E Liana Falcone; Alexandra Mangili; Alice M Tang; Clara Y Jones; Margo N Woods; Joseph F Polak; Christine A Wanke
Journal:  Am J Clin Nutr       Date:  2010-03-10       Impact factor: 7.045

7.  High rates of serum selenium deficiency among HIV- and HCV-infected and uninfected drug users in Buenos Aires, Argentina.

Authors:  Heidi B Sheehan; Jorge Benetucci; Estela Muzzio; Liliana Redini; Jorge Naveira; Marcela Segura; Mercedes Weissenbacher; Alice M Tang
Journal:  Public Health Nutr       Date:  2011-07-11       Impact factor: 4.022

8.  Comparative effects of acute-methionine loading on the plasma sulfur-amino acids in NAC-supplemented HIV+ patients and healthy controls.

Authors:  Roberto Carlos Burini; Maria Doroteia Borges-Santos; Fernando Moreto; Yong- Ming Yu
Journal:  Amino Acids       Date:  2018-02-01       Impact factor: 3.520

9.  Zinc status in HIV infected Ugandan children aged 1-5 years: a cross sectional baseline survey.

Authors:  Grace Ndeezi; James K Tumwine; Bjørn J Bolann; Christopher M Ndugwa; Thorkild Tylleskär
Journal:  BMC Pediatr       Date:  2010-09-21       Impact factor: 2.125

Review 10.  Regulation and function of selenoproteins in human disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Mariclair A Reeves; Marla J Berry
Journal:  Biochem J       Date:  2009-07-29       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.